Anthraquinones and analogs from Rhuem palmatum for treatment of estrogen receptor beta-mediated conditions

Details for Australian Patent Application No. 2009255626 (hide)

Owner BioNovo, Inc.

Inventors Cohen, Isaac

Agent Shelston IP

Pub. Number AU-A-2009255626

PCT Pub. Number WO2009/148620

Priority 61/059,686 06.06.08 US

Filing date 5 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 36/708 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/148620 Priority application(s): WO2009/148620

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009255648-Bioceramic and biopolymer composite

2009255619-Treatment of pain with gap junction modulation compounds